The article by Bénard et al. in this month's issue of The Journal of Nuclear Medicine (1) is an
important work, showing the feasibility of producing large quantities of 99mTc on a …

This paper discusses the benefits of obtaining 99mTc from non–fission reactor–produced
low-specific-activity 99Mo. This scenario is based on establishing a diversified chain of …

The uncertain availability of 99mTc has become a concern for nuclear medicine
departments across the globe. An issue for the United States is that currently it is dependent …

99mTc is currently produced by an aging fleet of nuclear reactors, which require enriched
uranium and generate nuclear waste. We report the development of a comprehensive …

99mTc is the most widely used radionuclide in nuclear medicine. The reactor stoppages that
occurred in recent years illustrated the vulnerability of the availability of radiotracers for …

There is a shortage of medical isotopes in the world today. Two of the most important isotope
producing reactors, the National Research Universal (NRU) reactor in Canada and the High …

SNM, ACNP, and radiopharmaceutical industry represen tatives have been working together
over the past few years to assure a constant supply of99mTc. We need to continue this work …

In what is becoming a perennial news cycle and a growing threat to the stability of nuclear
medicine practice, new shortages of radionuclides resulting from unexpected interruptions in …

99mTc, the most common radioisotope used in nuclear medicine, is produced in a nuclear
reactor from the decay of 99Mo. There are only a few aging nuclear reactors around the …

''Security of Supply of Medical Radioisotopes,''which was convened by the Nuclear Energy
Agency (NEA), a specialized agency within the Organization for Economic Cooperation and …